• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

    7.050 +0.300 (+4.44%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,854,967
    Open 6.730
    Bid (Size) 7.010 (600)
    Ask (Size) 7.490 (200)
    Prev. Close 6.750
    Today's Range 6.670 - 7.080
    52wk Range 5.280 - 16.38
    Shares Outstanding 98,983,261
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results ↗
     
    Via Benzinga
    News headline image
    Wave Life Sciences (WVE) Earnings Transcript ↗
    Wave Life Sciences (WVE) Earnings Transcript 
    Via The Motley Fool

    Performance

    YTD
    -47.1%
    -47.1%
    1 Month
    -1.8%
    -1.8%
    3 Month
    -30.5%
    -30.5%
    6 Month
    +18.5%
    +18.5%
    1 Year
    -50.9%
    -50.9%

    More News

    Read More
    News headline image
    Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Peering Into WAVE Life Sciences's Recent Short Interest ↗
    Via Benzinga
    Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why ↗
    Via Stocktwits
    News headline image
    Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
    Via MarketMinute
    Topics Artificial Intelligence Intellectual Property
    News headline image
    A Look Ahead: WAVE Life Sciences's Earnings Forecast ↗
    Via Benzinga
    News headline image
    Wave Life Sciences to Present at Upcoming Investor Conferences
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings) ↗
    Via Benzinga
    News headline image
    Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences ↗
    Via Benzinga
    News headline image
    Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday? ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates ↗
    Via Benzinga
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Nasdaq Gains Over 100 Points; Dollar Tree Post Upbeat Earnings ↗
    Via Benzinga

    Frequently Asked Questions

    Is Wave Life Sciences Ltd. - Ordinary Shares publicly traded?
    Yes, Wave Life Sciences Ltd. - Ordinary Shares is publicly traded.
    What exchange does Wave Life Sciences Ltd. - Ordinary Shares trade on?
    Wave Life Sciences Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares?
    The ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares is WVE on the Nasdaq Stock Market
    What is the current price of Wave Life Sciences Ltd. - Ordinary Shares?
    The current price of Wave Life Sciences Ltd. - Ordinary Shares is 7.050
    When was Wave Life Sciences Ltd. - Ordinary Shares last traded?
    The last trade of Wave Life Sciences Ltd. - Ordinary Shares was at 11/21/25 04:00 PM ET
    What is the market capitalization of Wave Life Sciences Ltd. - Ordinary Shares?
    The market capitalization of Wave Life Sciences Ltd. - Ordinary Shares is 697.83M
    How many shares of Wave Life Sciences Ltd. - Ordinary Shares are outstanding?
    Wave Life Sciences Ltd. - Ordinary Shares has 698M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.